BISTTRYOct 9, 18:19Live
EGEPO Balance Sheet and Financial StatementsNasmed Özel Sağlık Hizmetleri Ticaret A.Ş.
Main MarketEducation, Health, Sports and Social Services
5.800.34 (6.23%)
- Volume
- TRY 40.4M
- Day range
- 5.40 – 5.95
- Previous close
- 5.46
- Market cap
- TRY 2.9B
Last updated: Source: Borsa Istanbul, 15-minute delayed
The latest reported financial period for EGEPO is 2026/6. The table lists the last 5 periods from newest to oldest.
Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Nasmed Özel Sağlık Hizmetleri Ticaret A.Ş. (EGEPO), derived from KAP financial reports. Amounts are in TRY.
Financials
| Period | Sales (Quarterly, TRY) | EBITDA (Quarterly, TRY) | Net profit (Quarterly, TRY) |
|---|---|---|---|
| 2026/6 | 518.3M | 88.7M | −98.1M |
| 2026/3 | 438.3M | 59.7M | 36.4M |
| 2025/12 | 383.8M | 70.1M | 13.2M |
| 2025/9 | 179.1M | 19.6M | −7.5M |
| 2025/6 | 406.8M | 75M | −2.3M |
Frequently Asked Questions
How much profit did EGEPO report in its latest statements?
In the latest period (2026/6) EGEPO reported a net profit of TRY −98.1M, sales of TRY 518.3M and EBITDA of TRY 88.7M.
What does annualised mean?
Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.